Anakinra for therapy of rheumatoid arthritis
Tomoo, T.; Sumida, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 1): 534-537
2005
ISSN/ISBN: 0047-1852 PMID: 15799413 Document Number: 594728
Document emailed within 1 workday
Related Documents
Le Loët, X.; Nordström, D.; Rodriguez, M.; Rubbert, A.; Sarzi-Puttini, P.; Wouters, J.M.G.W.; Woolley, J.Michael.; Wright, N.; Lawrence, C.; Appleton, B. 2008: Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial Journal of Rheumatology 35(8): 1538-1544Kary, S.; Burmester, G.R. 2003: Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis International Journal of Clinical Practice 57(3): 231-234
Scott, I.C.; Ibrahim, F.; Simpson, G.; Kowalczyk, A.; White-Alao, B.; Hassell, A.; Plant, M.; Richards, S.; Walker, D.; Scott, D.L. 2016: A randomised trial evaluating anakinra in early active rheumatoid arthritis Clinical and Experimental Rheumatology 34(1): 88-93
Fleishmann, R.M. 2002: Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents Clinical and Experimental Rheumatology 20(5 Suppl 27: S35-S41
Bresnihan, B.; Newmark, R.; Robbins, S.; Genant, H.K. 2004: Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial Journal of Rheumatology 31(6): 1103-1111
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Koné-Paut, I.; Retornaz, K.; Garnier, J.M.; Bader-Meunier, B. 2007: Visceral leishmaniasis in a patient with systemic juvenile arthritis treated by IL-1RA agonist (Anakinra) Clinical and Experimental Rheumatology 25(1): 119
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Keitel, W.; Keitel, R. 1999: Basic therapy of rheumatoid arthritis. 2: Selection, long-term and combination therapy MMW Fortschritte der Medizin 141(37): 42-44
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Goriachev, D.V.; Erdes, S.F. 2004: Markov model of decision making for basic therapy of rheumatoid arthritis: oder of monotherapy and expenses for drug therapy Terapevticheskii Arkhiv 76(5): 35-39
Smith, R.D.; Polley, H.F. 1978: Rest therapy for rheumatoid arthritis Mayo Clinic Proceedings 53(3): 141-145
Sigidin, I.A.; Tsvetkova, E.S.; Bunchuk, N.V. 1981: New drugs in the therapy of rheumatoid arthritis Sovetskaia Meditsina 9: 94-97
Van der Lubbe, P.A.; Reiter, C.; Riethmüller, G.; Breedveld, F.C. 1993: Anti-CD4 therapy in rheumatoid arthritis Clinical and Experimental Rheumatology 11(Suppl 8): S151
Burstein, H. 2001: Gene therapy for rheumatoid arthritis Current Opinion in Molecular Therapeutics 3(4): 362-374